Quality generics
Our core business lies in developing, producing and distributing high-quality and specialty medicines following loss of their respective patent protection, thus helping secure access to affordable, quality healthcare for patients worldwide.
Generic medicines offer the same quality and safety profiles as reference products. Throughout their development and production processes, generics are required to adhere to the same rigorous standards of quality, safety and efficacy as originator products, standards that are closely monitored and enforced by the relevant regulatory authorities both prior to and post product approval. Our production plant is thus regularly inspected to ensure that it is and remains cGMP (current Good Manufacturing Practice) compliant ensuring continuous quality standards in the products.
New drug combinations
APREMILAST (Otezla / Celgene Europe BV) f.c. tabs
